Art

J-GLOBAL ID：201802276298254886   Reference number：18A0283306

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia

抗精神病薬多剤併用の高用量は統合失調症患者におけるペントシジンの血清中濃度の増加と関連している【Powered by NICT】

Author (18)： Sannohe Takahiro (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Ohnuma Tohru (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Takeuchi Masayoshi (Department of Advanced Medicine, Medical Research Institute,Kanazawa Medical University, Ishikawa, Japan) ,  Tani Eriko (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Miki Yasue (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Takeda Mayu (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Katsuta Narimasa (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Takebayashi Yuto (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Nakamura Toru (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Nishimon Shohei (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Kimoto Ayako (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Higashiyama Ryoko (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Shibata Nobuto (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Gohda Tomohito (Division of Nephrology, Department of Internal Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Suzuki Yusuke (Division of Nephrology, Department of Internal Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Yamagishi Sho-ichi (Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan) ,  Tomino Yasuhiko (Division of Nephrology, Department of Internal Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan) ,  Arai Heii (Juntendo University Schizophrenia Projects (JUSP), Department of Psychiatry, Juntendo University, Faculty of Medicine, Tokyo, Japan)
Material： Progress in Neuro-Psychopharmacology & Biological Psychiatry  (PNP & BP Journal)
Volume： 76  Page： 42-48  Publication year： 2017 
JST Material Number： T0252A  ISSN： 0278-5846  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Carbonyl stress in patients wi...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0283306&from=J-GLOBAL&jstjournalNo=T0252A") }}

Thesaurus term： antianxiety drug ,  *serum ,  therapy ,  *patient ,  *serum concentration ,  administration(biology) ,  population(statistics) ,  *psychotic disorder ,  cohort study ,  antiparkinson drug ,  *schizophrenia ,  *antipsychotic agent
Semi thesaurus term： 非定型抗精神病薬 ,  *多剤併用 , 【Automatic Indexing@JST】

Author keywords (5)： Antipsychotics ,  Dose ,  Pentosidine ,  Polypharmacy ,  Schizophrenia

JST classification (2)： Drug therapy(=pharmacotherapy)for mental disorders  (GR04020D) ,  Clinical application of psychotropic drugs  (GW03110J)

Substance index (1)： Pentosidine

Terms in the title (6)： 抗精神病薬 ,  多剤併用 ,  高用量 ,  統合失調症患者 ,  ペントシジン ,  血清中濃度